The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma
暂无分享,去创建一个
A. Sheri | S. Law | S. Merrick | P. Dupont | L. Heptinstall | P. Bass | D. Hanna
[1] M. Suarez‐Almazor,et al. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature , 2019, Journal of Immunotherapy for Cancer.
[2] L. E. Aguirre,et al. Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue. , 2018, The oncologist.
[3] Gregory Riely,et al. Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Perazella,et al. Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future. , 2018, Journal of the American Society of Nephrology : JASN.
[5] S. Jang,et al. Complete Tumor Response to Pembrolizumab and Allograft Preservation in Renal Allograft Recipient on Immunosuppressive Therapy. , 2017, Journal of oncology practice.
[6] H. Lai,et al. Tumor regression and preservation of graft function after combination with anti-PD-1 immunotherapy without immunosuppressant titration. , 2017 .
[7] N. Karanth,et al. Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report , 2017, Journal of Medical Case Reports.
[8] W. Chon,et al. Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients , 2017, Clinical kidney journal.
[9] K. Jhaveri,et al. Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab. , 2017, The New England journal of medicine.
[10] J. Taube,et al. Tumor Regression and Allograft Rejection after Administration of Anti-PD-1. , 2016, The New England journal of medicine.
[11] E. Woodle,et al. Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.